National Cancer Institute (United States)

Public Institution · Bethesda, United States

2,500–5,000 researchers · 10,000–25,000 publications (5-year) · 250–500 clinical trials (5-year)

Research topics: Urogenital Neoplasms, Carcinoma, T-Lymphocytes, Breast Diseases, Breast Neoplasms, RNA Viruses, Lymphoproliferative Disorders, Epidemiologic Studies, Computing Methodologies, Gastrointestinal Neoplasms

Top journals: Nat Commun, J Natl Cancer Inst, Cancers (Basel), bioRxiv, Sci Rep

Clinical research areas: Carcinoma, Urogenital Neoplasms, Thoracic Neoplasms, Lung Neoplasms, Social Sciences, Bronchial Neoplasms

Top researchers: Huang Jing (Top 1% worldwide in Gastrointestinal Neoplasms), Wang Xiaoyu (Top 1% worldwide in Nanostructures), Chanock Stephen J (Top 10 worldwide in Genome-Wide Association Study), Rosenberg Steven A (Top 10 worldwide in T-Lymphocytes), Choyke Peter L (Top 1% worldwide in Urogenital Neoplasms), Gonzalez Frank J (Top 100 worldwide in Gene Components), Pommier Yves (Top 1% worldwide in Base Sequence)

ScienceLeadR experts at this institution: Alejandro A Schäffer

About ScienceLeadR: How it works · Top KOL ranking

{{ sectionLabels.bio }}

No public content here yet.

No public content here yet.

No public content here yet.

No public content here yet.

No public content here yet.